These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30258875)

  • 1. Cancer stem cells may contribute to the difficulty in treating cancer.
    Iseghohi SO
    Genes Dis; 2016 Mar; 3(1):7-10. PubMed ID: 30258875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell plasticity and heterogeneity in cancer.
    Marjanovic ND; Weinberg RA; Chaffer CL
    Clin Chem; 2013 Jan; 59(1):168-79. PubMed ID: 23220226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast-cancer stem cells-beyond semantics.
    Badve S; Nakshatri H
    Lancet Oncol; 2012 Jan; 13(1):e43-8. PubMed ID: 22225725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular determinants of cancer stem cell dormancy--do age and coagulation system play a role?
    Rak J; Milsom C; Yu J
    APMIS; 2008; 116(7-8):660-76. PubMed ID: 18834410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cells (CSCs), cervical CSCs and targeted therapies.
    Huang R; Rofstad EK
    Oncotarget; 2017 May; 8(21):35351-35367. PubMed ID: 27343550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer stem cells and epithelial mesenchymal plasticity - Implications for chemoresistance.
    Pinto CA; Widodo E; Waltham M; Thompson EW
    Cancer Lett; 2013 Nov; 341(1):56-62. PubMed ID: 23830804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cell plasticity and tumor hierarchy.
    Cabrera MC; Hollingsworth RE; Hurt EM
    World J Stem Cells; 2015 Jan; 7(1):27-36. PubMed ID: 25621103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro models of cancer stem cells and clinical applications.
    S Franco S; Szczesna K; Iliou MS; Al-Qahtani M; Mobasheri A; Kobolák J; Dinnyés A
    BMC Cancer; 2016 Sep; 16(Suppl 2):738. PubMed ID: 27766946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mathematical study of the impact of cell plasticity on tumour control probability.
    Forouzannia F; Sivaloganathan S; Kohandel M
    Math Biosci Eng; 2020 Aug; 17(5):5250-5266. PubMed ID: 33120551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine-mediated cancer stem cell therapy.
    Shen S; Xia JX; Wang J
    Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Stem Cell Hypothesis for Therapeutic Innovation in Clinical Oncology? Taking the Root Out, Not Chopping the Leaf.
    Dzobo K; Senthebane DA; Rowe A; Thomford NE; Mwapagha LM; Al-Awwad N; Dandara C; Parker MI
    OMICS; 2016 Dec; 20(12):681-691. PubMed ID: 27930094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic cancer stem cells: new molecular targets for cancer therapy.
    Leirós GJ; Balañá ME
    Curr Pharm Biotechnol; 2011 Nov; 12(11):1909-22. PubMed ID: 21470128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization and targeting of LGR5
    Shimokawa M; Ohta Y; Nishikori S; Matano M; Takano A; Fujii M; Date S; Sugimoto S; Kanai T; Sato T
    Nature; 2017 May; 545(7653):187-192. PubMed ID: 28355176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cells: A product of clonal evolution?
    van Niekerk G; Davids LM; Hattingh SM; Engelbrecht AM
    Int J Cancer; 2017 Mar; 140(5):993-999. PubMed ID: 27676693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cell: fundamental experimental pathological concepts and updates.
    Islam F; Qiao B; Smith RA; Gopalan V; Lam AK
    Exp Mol Pathol; 2015 Apr; 98(2):184-91. PubMed ID: 25659759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Stem Cell Plasticity - A Deadly Deal.
    Thankamony AP; Saxena K; Murali R; Jolly MK; Nair R
    Front Mol Biosci; 2020; 7():79. PubMed ID: 32426371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?
    Dunning NL; Laversin SA; Miles AK; Rees RC
    Cancer Immunol Immunother; 2011 Aug; 60(8):1181-93. PubMed ID: 21688178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
    Eun K; Ham SW; Kim H
    BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.